Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

31,175 trials

NCT06693284
Recruiting
A Window of Opportunity Trial of Mirdametinib Plus Vorinostat for NF1 Associated, H3K27 Trimethylation Deficient Malignant Peripheral Nerve Sheath Tumor [MPNST]
Early phase 1 · United States · 1 site
Registry update: 29 May 2026
NCT07755826
Recruiting
Repotrectinib Post-Marketing Surveillance in Pediatric Patients With NTRK Fusion-Positive Tumors in Japan
Not applicable · Japan · 2 sites
Registry update: 10 Aug 2026
NCT07655115
Recruiting
Single Dose Double-blind, Placebo-controlled Cross-over (SDDBPCCO) Shiftability Study, Will be Followed by a 10-week Open-label Study With Arbaclofen (4 Weeks of Titration and Then 6 Weeks of Active/Stable Treatment). The Effects of Arbaclofen on Target EEG and ERG Metrics Will be Associated With th
Phase 3 · Spain, France · 5 sites
Registry update: 17 Jun 2026
NCT07231822
Recruiting
The Investigation of the Effectiveness of Virtual Reality Applications in Postmenopausal Osteoporosis Patients
Not applicable · 1 site
Registry update: 27 Feb 2026
NCT07216027
Recruiting
A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema
Phase 2 · Bulgaria, Canada, China, Czechia, Germany, France, Japan, Poland, United States · 53 sites
Registry update: 5 Nov 2026
NCT07593352
Recruiting
Renal Dysfunction in Patients With Inflammatory Bowel Disease and the General Population (NEPHRO-IBD)
Not applicable · Poland · 1 site
Registry update: 18 May 2026
NCT07251114
Recruiting
AI-assisted Endoscopic Ultrasound Grading of Early Esophageal Cancer Invasion Depth: A Multicenter, Prospective, Randomized Cohort Study
Not applicable · China · 5 sites
Registry update: 26 Nov 2025
NCT07242222
Recruiting
Erdosteine in the Treatment of Nonalcoholic Fatty Liver Disease
Phase 1/2 · Egypt · 1 site
Registry update: 10 Dec 2025
NCT07246278
Recruiting
Celecoxib in Parkinson Disease as Adjuvant Therapy
Phase 1/2 · Egypt · 1 site
Registry update: 5 Dec 2025
NCT07235007
Recruiting
Repeated Endobiliary Radiofrequency Ablation Plus Durvalumab, Gemcitabine, and Cisplatin for Unresectable Extrahepatic Cholangiocarcinoma
Not applicable · Japan, South Korea · 8 sites
Registry update: 13 Jan 2026
NCT06282055
Recruiting
Trajectories in Insulin Sensitivity Across MEnstrual cycleS in Women With Type 1 Diabetes
Not applicable · Switzerland · 1 site
Registry update: 3 Dec 2025
2024-511392-15-00
Recruiting
A clinical study to evaluate the safety, efficacy, and impact on quality of life of capivasertib alongside routine endocrine treatment in patients with HR+/HER2- advanced breast cancer and disease progression despite prior hormone-based treatment (CAPIcorn)
Phase 3 · Belgium, Germany, Portugal · 24 sites
Registry update: 26 Aug 2026
NCT07129616
Recruiting
Remote Monitoring of Asthma in Children and Young People
Not applicable · United Kingdom · 1 site
Registry update: 27 Oct 2026
NCT07239310
Recruiting
Neuclare Device for Temporary Improvement of Executive Function in Patients With Mild Cognitive Impairment and Prodromal Alzheimer's Disease
Not applicable · South Korea · 7 sites
Registry update: 7 Aug 2026
NCT07171216
Recruiting
The Effect of REgulation of PArathyroId hoRmone in Patients With Chronic Kidney Disease to Investigate the Change in Bone Mineral Density
Not applicable · Denmark · 1 site
Registry update: 6 Jan 2026
NCT07272798
Recruiting
Cardiac Self-Efficacy in Patients With Chronic Thromboembolic Pulmonary Hypertension
Not applicable · Syria · 1 site
Registry update: 17 Dec 2025
NCT07268768
Recruiting
PERSONOLOGICAL STRUCTURE, COGNITIVE FUNCTIONS AND CENTRAL SENSITIZATION IN HEADACHE
Not applicable · Italy · 1 site
Registry update: 8 Dec 2025
NCT06970275
Recruiting
To Assess the Correlation of High-resolution Specimen PET-CT Imaging, Using the XEOS AURA 10 PET-CT, With the Histopathology Results and Long-term Outcome of Patients Undergoing Resective Cancer Surgery.
Not applicable · Belgium, Germany, United Kingdom, Netherlands · 5 sites
Registry update: 15 Sept 2026
NCT07592676
Recruiting
Transition From Pediatric to Adult Care in Epilepsy
Not applicable · Italy · 1 site
Registry update: 18 May 2026
NCT07375563
Recruiting
Chemoimmunotherapy Combined With Autologous NK Cell Therapy for Pediatric Patients With Refractory and Relapsed High-Risk Neuroblastoma and Ganglioneuroblastoma
Phase 3 · Russia · 1 site
Registry update: 29 Jan 2026

Ordered by registry start date. Freshness and sponsorship never change the order.